Skip to main content
Top
Published in: Indian Journal of Surgery 1/2016

01-02-2016 | Review Article

Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management

Authors: George Galyfos, Georgios A. Karantzikos, Nikolaos Kavouras, Argiri Sianou, Konstantinos Palogos, Konstantinos Filis

Published in: Indian Journal of Surgery | Issue 1/2016

Login to get access

Abstract

Extraosseous Ewing sarcomas (EESs) are rare tumours originating from soft tissues. Their clinical picture depends mainly on the primary site of the sarcoma. Patient characteristics and outcomes seem to be different in EES compared to patients with skeletal Ewing sarcoma, with implications for patient care and prognosis. However, multimodality therapeutic strategies are recommended for all types of the Ewing tumour family. The available diagnostic tools include ultrasonographic evaluation and computed tomography (CT) or magnetic resonance imaging as well as histopathologic and immunohistochemical tissue examination. Several histologic and genetic biomarkers have been established, although their utilization needs to be further tested by larger prospective studies. Regarding localized disease, the recommended treatment remains surgery. However, chemotherapy can be added to achieve improved survival, with neoadjuvant regimens showing more promising results than adjuvant regimens. Radiotherapy is an option to obtain local control, although its complications have reduced its utilization. In metastatic or recurrent disease, systematic chemotherapy improves survival.
Literature
1.
go back to reference Paoletti H, Colineau X, Acalet L et al (1999) Ewing’s sarcoma of the soft tissues: apropos of 3 cases and review of the literature. J Radiol 80:477–482PubMed Paoletti H, Colineau X, Acalet L et al (1999) Ewing’s sarcoma of the soft tissues: apropos of 3 cases and review of the literature. J Radiol 80:477–482PubMed
2.
go back to reference Ahmad R, Mayol BR, Davis M, Rougraff BT (1999) Extraskeletal Ewing’s sarcoma. Cancer 85:725–731CrossRefPubMed Ahmad R, Mayol BR, Davis M, Rougraff BT (1999) Extraskeletal Ewing’s sarcoma. Cancer 85:725–731CrossRefPubMed
3.
go back to reference Cheung CC, Kandel RA, Bell RS, Mathews RE, Ghazarian MD (2001) (2001) Extraskeletal Ewing sarcoma in a in a 77-year-old woman. Arch Pathol Lab Med 125:1358–1360PubMed Cheung CC, Kandel RA, Bell RS, Mathews RE, Ghazarian MD (2001) (2001) Extraskeletal Ewing sarcoma in a in a 77-year-old woman. Arch Pathol Lab Med 125:1358–1360PubMed
5.
go back to reference Maheshwari V, Siddiqui F, Adreena K, Sherwani RK, Jain A, Alam K (2009) Extraskeletal Ewing’s sarcoma—a case report. Internet J Orthop Surg 14:1 Maheshwari V, Siddiqui F, Adreena K, Sherwani RK, Jain A, Alam K (2009) Extraskeletal Ewing’s sarcoma—a case report. Internet J Orthop Surg 14:1
6.
7.
go back to reference O’Keeffe F, Lorigan JG, Wallace S (1990) Radiological features of extraskeletal Ewing sarcoma. Br J Radiol 63:456–460CrossRefPubMed O’Keeffe F, Lorigan JG, Wallace S (1990) Radiological features of extraskeletal Ewing sarcoma. Br J Radiol 63:456–460CrossRefPubMed
8.
go back to reference Shirkhoda A, Peuchot M (1989) Extraosseous Ewing’s sarcoma. Computed tomography evaluation before and after chemotherapy. Clin Imaging 13:142–146CrossRefPubMed Shirkhoda A, Peuchot M (1989) Extraosseous Ewing’s sarcoma. Computed tomography evaluation before and after chemotherapy. Clin Imaging 13:142–146CrossRefPubMed
9.
go back to reference Vanel D, Contsso G, Couanet D et al (1982) Computed tomography in the evaluation of 41 cases of Ewing’s sarcoma. Skelet Radiol 9:8–13CrossRef Vanel D, Contsso G, Couanet D et al (1982) Computed tomography in the evaluation of 41 cases of Ewing’s sarcoma. Skelet Radiol 9:8–13CrossRef
10.
go back to reference Frouge C, Vanel D, Coffre C et al (1988) The role of magnetic resonance imaging in the evaluation of Ewing sarcoma. Skelet Radiol 17:387–392CrossRef Frouge C, Vanel D, Coffre C et al (1988) The role of magnetic resonance imaging in the evaluation of Ewing sarcoma. Skelet Radiol 17:387–392CrossRef
11.
go back to reference Pinto A, Dickman P, Parham D (2011) Pathobiologic markers of the Ewing Sarcoma family of tumors: state of the art and prediction of behaviour. Sarcoma Article ID 856190 Pinto A, Dickman P, Parham D (2011) Pathobiologic markers of the Ewing Sarcoma family of tumors: state of the art and prediction of behaviour. Sarcoma Article ID 856190
12.
go back to reference Buch AC, Panicker N, Sarawagi S, Anwekar S, Kharat AT (2010) Fine needle aspiration cytology diagnosis of paravertebral extraosseous Ewing’s sarcoma. J Cytol 27:146–148CrossRefPubMedPubMedCentral Buch AC, Panicker N, Sarawagi S, Anwekar S, Kharat AT (2010) Fine needle aspiration cytology diagnosis of paravertebral extraosseous Ewing’s sarcoma. J Cytol 27:146–148CrossRefPubMedPubMedCentral
13.
go back to reference Delattre O, Zucman J, Melot T et al (1994) The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294–299CrossRefPubMed Delattre O, Zucman J, Melot T et al (1994) The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294–299CrossRefPubMed
14.
go back to reference Li Q, Cui W, Abulajiang G et al (2014) Application of immunohistochemistry in the diagnosis of small round blue-cell tumors of soft tissue. Clin Lab 60:1383–1392PubMed Li Q, Cui W, Abulajiang G et al (2014) Application of immunohistochemistry in the diagnosis of small round blue-cell tumors of soft tissue. Clin Lab 60:1383–1392PubMed
15.
16.
go back to reference Sorensen PH, Liu XF, Delattre O et al (1993) Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol 2:147–157CrossRefPubMed Sorensen PH, Liu XF, Delattre O et al (1993) Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol 2:147–157CrossRefPubMed
17.
go back to reference Lewis TB, Coffin CM, Bernard PS (2007) Differentiating Ewing’s sarcoma from other round blue-cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues. Mod Pathol 20:397–404CrossRefPubMed Lewis TB, Coffin CM, Bernard PS (2007) Differentiating Ewing’s sarcoma from other round blue-cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues. Mod Pathol 20:397–404CrossRefPubMed
18.
go back to reference Sumegi J, Nishio J, Nelson M, Frayer RW, Perry D, Bridge JA (2011) A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol 24:333–342CrossRefPubMed Sumegi J, Nishio J, Nelson M, Frayer RW, Perry D, Bridge JA (2011) A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol 24:333–342CrossRefPubMed
19.
go back to reference Romeo S, Dei Tos AP (2010) Soft tissue tumors associated with EWSR1 translocation. Virchows Arch 456:219–234CrossRefPubMed Romeo S, Dei Tos AP (2010) Soft tissue tumors associated with EWSR1 translocation. Virchows Arch 456:219–234CrossRefPubMed
20.
21.
go back to reference Avigad S, Cohen IJ, Zilberstein J et al (2004) The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer 100:1053–1058CrossRefPubMed Avigad S, Cohen IJ, Zilberstein J et al (2004) The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer 100:1053–1058CrossRefPubMed
22.
go back to reference Jahromi MS, Jones KB, Schiffman JD (2011) Copy number alterations and methylation in Ewing’s sarcoma. Sarcoma Article ID 362173 Jahromi MS, Jones KB, Schiffman JD (2011) Copy number alterations and methylation in Ewing’s sarcoma. Sarcoma Article ID 362173
23.
go back to reference Shukla N, Schiffman J, Reed D, COG Ewing Sarcoma Biology Committee et al (2013) Biomarkers in Ewing sarcoma: the promise and challenge of personalized medicine. A report from the Children’s Oncology Group. Front Oncol 6(3):141 Shukla N, Schiffman J, Reed D, COG Ewing Sarcoma Biology Committee et al (2013) Biomarkers in Ewing sarcoma: the promise and challenge of personalized medicine. A report from the Children’s Oncology Group. Front Oncol 6(3):141
24.
go back to reference Biermann JS (2013) Updates in the treatment of bone cancer. J Natl Compr Cancer Netw 11:681–683 Biermann JS (2013) Updates in the treatment of bone cancer. J Natl Compr Cancer Netw 11:681–683
25.
go back to reference Rud NP, Reiman HM, Pritchard DJ, Frassica FJ, Smithson WA (1989) Extraosseous Ewing’s sarcoma. A study of 42 cases. Cancer 64:1548–1553CrossRefPubMed Rud NP, Reiman HM, Pritchard DJ, Frassica FJ, Smithson WA (1989) Extraosseous Ewing’s sarcoma. A study of 42 cases. Cancer 64:1548–1553CrossRefPubMed
26.
go back to reference Covelli HD, Beekman JF, Kingry RL (1980) Extraskeletal Ewing’s sarcoma: prolonged survival with recurrence after operation. South Med J 73:1294–1295CrossRefPubMed Covelli HD, Beekman JF, Kingry RL (1980) Extraskeletal Ewing’s sarcoma: prolonged survival with recurrence after operation. South Med J 73:1294–1295CrossRefPubMed
27.
go back to reference Qureshi SS, Laskar S, Kembhavi S et al (2013) Extraskeletal Ewing sarcoma in children and adolescents: impact of narrow but negative surgical margin. Pediatr Surg Int 29:1303–1309CrossRefPubMed Qureshi SS, Laskar S, Kembhavi S et al (2013) Extraskeletal Ewing sarcoma in children and adolescents: impact of narrow but negative surgical margin. Pediatr Surg Int 29:1303–1309CrossRefPubMed
28.
go back to reference Paulussen M, Ahrens S, Dunst J et al (2001) Localized Ewing tumor of bone: final results of the cooperative Ewing’s sarcoma study CESS 86. J Clin Oncol 19:1818–1829PubMed Paulussen M, Ahrens S, Dunst J et al (2001) Localized Ewing tumor of bone: final results of the cooperative Ewing’s sarcoma study CESS 86. J Clin Oncol 19:1818–1829PubMed
30.
31.
go back to reference Vogin G, Helfre S, Glorion C et al (2013) Local control and sequelae in localised Ewing tumours of the spine: a French retrospective study. Eur J Cancer 49:1314–1323CrossRefPubMed Vogin G, Helfre S, Glorion C et al (2013) Local control and sequelae in localised Ewing tumours of the spine: a French retrospective study. Eur J Cancer 49:1314–1323CrossRefPubMed
32.
go back to reference Bernstein M, Kovar H, Paulussen M et al (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11:503–519CrossRefPubMed Bernstein M, Kovar H, Paulussen M et al (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11:503–519CrossRefPubMed
33.
go back to reference Schuck A, Ahrens S, Paulussen M et al (2003) Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 55:168–177CrossRefPubMed Schuck A, Ahrens S, Paulussen M et al (2003) Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 55:168–177CrossRefPubMed
34.
go back to reference Iwata S, Yonemoto T, Ishii T, Kumagai K et al (2013) Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing’s sarcoma family of tumors. Int J Clin Oncol 18:1114–1118CrossRefPubMed Iwata S, Yonemoto T, Ishii T, Kumagai K et al (2013) Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing’s sarcoma family of tumors. Int J Clin Oncol 18:1114–1118CrossRefPubMed
35.
go back to reference Bacci G, Balladelli A, Forni C et al (2007) Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years. Cancer 109:780–786CrossRefPubMed Bacci G, Balladelli A, Forni C et al (2007) Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years. Cancer 109:780–786CrossRefPubMed
36.
go back to reference Castex MP, Rubie H, Stevens MC et al (2007) Extraosseous localized Ewing tumors: improved outcome with anthracyclines—the French Society of Pediatric Oncology and International Society of Pediatric Oncology. J Clin Oncol 25:1176–1182CrossRefPubMed Castex MP, Rubie H, Stevens MC et al (2007) Extraosseous localized Ewing tumors: improved outcome with anthracyclines—the French Society of Pediatric Oncology and International Society of Pediatric Oncology. J Clin Oncol 25:1176–1182CrossRefPubMed
37.
go back to reference Raney RB, Asmar L, Newton WA Jr et al (1997) Ewing’s sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972–1991. J Clin Oncol 15:574–582PubMed Raney RB, Asmar L, Newton WA Jr et al (1997) Ewing’s sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972–1991. J Clin Oncol 15:574–582PubMed
38.
go back to reference Shamberger RC, LaQuaglia MP, Gebhardt MC et al (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563–567PubMedPubMedCentral Shamberger RC, LaQuaglia MP, Gebhardt MC et al (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563–567PubMedPubMedCentral
39.
go back to reference Krasin MJ, Davidoff AM, Rodriguez-Galindo C et al (2005) Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors. Cancer 104:367–373CrossRefPubMed Krasin MJ, Davidoff AM, Rodriguez-Galindo C et al (2005) Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors. Cancer 104:367–373CrossRefPubMed
40.
go back to reference Kinsella TJ, Triche TJ, Dickman PS, Costa J, Tepper JE, Glaubiger D (1983) Extraskeletal Ewing’s sarcoma: results of combined modality treatment. J Clin Oncol 1:489–495PubMed Kinsella TJ, Triche TJ, Dickman PS, Costa J, Tepper JE, Glaubiger D (1983) Extraskeletal Ewing’s sarcoma: results of combined modality treatment. J Clin Oncol 1:489–495PubMed
41.
go back to reference Grier HE, Krailo MD, Tarbell NJ et al (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694–701CrossRefPubMed Grier HE, Krailo MD, Tarbell NJ et al (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694–701CrossRefPubMed
42.
go back to reference Tao HT, Hu Y, Wang JL et al (2013) Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients. Asian Pac J Cancer Prev 14:2967–2971CrossRefPubMed Tao HT, Hu Y, Wang JL et al (2013) Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients. Asian Pac J Cancer Prev 14:2967–2971CrossRefPubMed
43.
go back to reference Womer RB, West DC, Krailo M et al (2012) Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group. J Clin Oncol 30:4148–4154CrossRefPubMedPubMedCentral Womer RB, West DC, Krailo M et al (2012) Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group. J Clin Oncol 30:4148–4154CrossRefPubMedPubMedCentral
44.
go back to reference Paulussen M, Craft AW, Lewis I et al (2008) Results of the EICESS-92 study: two randomized trials of Ewing’s sarcoma treatment—cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 26:4385–4393CrossRefPubMed Paulussen M, Craft AW, Lewis I et al (2008) Results of the EICESS-92 study: two randomized trials of Ewing’s sarcoma treatment—cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 26:4385–4393CrossRefPubMed
45.
go back to reference DuBois SG, Grier HE (2009) Chemotherapy: the role of ifosfamide and etoposide in Ewing sarcoma. Nat Rev Clin Oncol 6:251–253CrossRefPubMed DuBois SG, Grier HE (2009) Chemotherapy: the role of ifosfamide and etoposide in Ewing sarcoma. Nat Rev Clin Oncol 6:251–253CrossRefPubMed
46.
go back to reference Evans R, Nesbit M, Askin F (1985) Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing’s sarcoma of the pelvic bones. Int J Radiat Oncol Biol Phys 11:129–136CrossRefPubMed Evans R, Nesbit M, Askin F (1985) Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing’s sarcoma of the pelvic bones. Int J Radiat Oncol Biol Phys 11:129–136CrossRefPubMed
47.
go back to reference El Weshi A, Memon M, Raja M et al (2004) VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors. Am J Clin Oncol 27:529–534CrossRefPubMed El Weshi A, Memon M, Raja M et al (2004) VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors. Am J Clin Oncol 27:529–534CrossRefPubMed
48.
go back to reference Felgenhauer JL, Nieder ML, Krailo MD et al (2013) A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: a Children’s Oncology Group (COG) Phase II study NCT00061893. Pediatr Blood Cancer 60:409–414CrossRefPubMedPubMedCentral Felgenhauer JL, Nieder ML, Krailo MD et al (2013) A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: a Children’s Oncology Group (COG) Phase II study NCT00061893. Pediatr Blood Cancer 60:409–414CrossRefPubMedPubMedCentral
49.
go back to reference Ladenstein R, Pötschger U, Le Deley MC et al (2010) Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol 28:3284–3291CrossRefPubMed Ladenstein R, Pötschger U, Le Deley MC et al (2010) Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol 28:3284–3291CrossRefPubMed
50.
go back to reference Tural D, Molinas Mandel N, Dervisoglu S et al (2012) Extraskeletal Ewing’s sarcoma family of tumors in adults: prognostic factors and clinical outcome. Jpn J Clin Oncol 42:420–426CrossRefPubMed Tural D, Molinas Mandel N, Dervisoglu S et al (2012) Extraskeletal Ewing’s sarcoma family of tumors in adults: prognostic factors and clinical outcome. Jpn J Clin Oncol 42:420–426CrossRefPubMed
51.
go back to reference Shannon OW, Denbo JW, Billups CA et al (2012) Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children’s research hospital experience. Ann Surg Oncol 19:3816–3822CrossRef Shannon OW, Denbo JW, Billups CA et al (2012) Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children’s research hospital experience. Ann Surg Oncol 19:3816–3822CrossRef
52.
go back to reference Lee J, Hoang BH, Ziogas A, Zell JA (2010) Analysis of prognostic factors in Ewing sarcoma using a population based cancer registry. Cancer 116:1964–1973CrossRefPubMed Lee J, Hoang BH, Ziogas A, Zell JA (2010) Analysis of prognostic factors in Ewing sarcoma using a population based cancer registry. Cancer 116:1964–1973CrossRefPubMed
Metadata
Title
Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management
Authors
George Galyfos
Georgios A. Karantzikos
Nikolaos Kavouras
Argiri Sianou
Konstantinos Palogos
Konstantinos Filis
Publication date
01-02-2016
Publisher
Springer India
Published in
Indian Journal of Surgery / Issue 1/2016
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-015-1399-0

Other articles of this Issue 1/2016

Indian Journal of Surgery 1/2016 Go to the issue